Alnylam Pharmaceuticals reported $-146732000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amgen AMGN:US $ 2500M 196M
Arrowhead Research ARWR:US $ 41.55M 104.87M
Avrobio Inc AVRO:US $ -29418000 1.46M
Biocryst Pharmaceuticals BCRX:US $ -49957000 2.22M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Moderna Inc MRNA:US 4.23B 1.18B
Novartis NVS:US 3.15B 266M
Ptc Therapeutics PTCT:US $ -86522000 1.79M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Regulus Therapeutics RGLS:US $ -6569000 391K
Sangamo Biosciences SGMO:US $ -45261000 5.36M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Takeda 4502:JP -1619000000 144.87B
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
Xencor XNCR:US $ 26.47M 65.19M
YTE INCY:US $ 127.66M 7.71M